رجوع
33
مُدرج أيضًا باسم
WILLF
OTC
نطاق اليوم
KWD 13.45
KWD 14.49
نطاق 52 أسبوعًا
KWD 13.45
KWD 21.93
حجم التداول
1
متوسط 50 يوم / 200 يوم
KWD 15.24
/
KWD 17.81
الإغلاق السابق
KWD 13.45
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 3.8 | 0.3 |
| P/B | 0.6 | 2.9 |
| ROE % | 15.9 | 3.7 |
| Net Margin % | 6.7 | 3.8 |
| Rev Growth 5Y % | 6.4 | 10.0 |
| D/E | 2.1 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
27 B | 0 |
| FY2026 |
KWD 7.370
KWD 7.268 – KWD 7.631
|
25 B | 1 |
النقاط الرئيسية
Revenue grew 6.43% annually over 5 years — modest growth
Earnings declined -35.27% over the past year
ROE of 15.92% — decent returns on equity
Debt/Equity of 2.13 — high leverage
Generating 3.18B in free cash flow
P/E of 3.84 — trading at a low valuation
النمو
Revenue Growth (5Y)
6.43%
Revenue (1Y)2.46%
Earnings (1Y)-35.27%
FCF Growth (3Y)-5.86%
الجودة
Return on Equity
15.92%
ROIC9.51%
Net Margin6.73%
Op. Margin17.01%
الأمان
Debt / Equity
2.13
Current Ratio1.36
Interest Coverage7.35
التقييم
P/E Ratio
3.84
P/B Ratio0.60
EV/EBITDA6.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.46% | Revenue Growth (3Y) | 1.17% |
| Earnings Growth (1Y) | -35.27% | Earnings Growth (3Y) | -7.22% |
| Revenue Growth (5Y) | 6.43% | Earnings Growth (5Y) | -11.45% |
| Profitability | |||
| Revenue (TTM) | 22.97B | Net Income (TTM) | 1.55B |
| ROE | 15.92% | ROA | 3.95% |
| Gross Margin | 75.62% | Operating Margin | 17.01% |
| Net Margin | 6.73% | Free Cash Flow (TTM) | 3.18B |
| ROIC | 9.51% | FCF Growth (3Y) | -5.86% |
| Safety | |||
| Debt / Equity | 2.13 | Current Ratio | 1.36 |
| Interest Coverage | 7.35 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 3.84 | P/B Ratio | 0.60 |
| P/S Ratio | 0.26 | PEG Ratio | -0.80 |
| EV/EBITDA | 6.55 | Dividend Yield | 0.00% |
| Market Cap | 5.93B | Enterprise Value | 25.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22.97B | 22.42B | 22.44B | 19.71B | 17.91B |
| Net Income | 1.55B | 2.39B | 1.80B | 2.08B | 2.51B |
| EPS (Diluted) | 3.52 | 5.45 | 4.02 | 4.61 | 5.35 |
| Gross Profit | 17.37B | 17.09B | 16.54B | 14.67B | 13.46B |
| Operating Income | 3.91B | 4.40B | 4.15B | 3.21B | 3.66B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 39.07B | 32.45B | 30.55B | 29.86B | 24.86B |
| Total Liabilities | 29.16B | 22.81B | 21.21B | 21.30B | 16.88B |
| Shareholders' Equity | 9.84B | 9.56B | 9.26B | 8.56B | 7.98B |
| Total Debt | 20.99B | 15.68B | 14.45B | 15.08B | 11.34B |
| Cash & Equivalents | 1.33B | 1.11B | 1.14B | 1.13B | 1.17B |
| Current Assets | 10.08B | 9.92B | 9.38B | 10.02B | 7.89B |
| Current Liabilities | 7.42B | 6.10B | 6.86B | 11.57B | 10.97B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#293 of 670
النشاط الأخير
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026